Summary
Cardiotoxins are small basic proteins (7 000 daltons) that are found in the venoms of Elapidae snakes. Although they are structurally close to a-neurotoxins present in the same secretions, their activity is related to their ability to interact with every cell membrane inducing, near micromolar concentration, the modification of its biological properties and/or physical structure. The mode of action of cardiotoxins, on a molecular level, is still under investigation. However, lipid-protein interactions are more and more involved in their binding to membrane and in their activities. Using new experimental data a better definition of phospholipid cardiotoxin interaction is arrived at and a tentative molecular explanation of the pharmacological activities of these proteins is presented and discussed.
Similar content being viewed by others
References
Karlson, E., 1979. Handbook of Experimental Pharmacology (Lee C.-Y., ed.), Vol. 52, pp. 159–204, Springer Verlag, Berlin, Heidelberg, New York.
Visser, L. and Louw, A., 1978. Biochim. Biophys. Acta 533: 80–89.
Drake, A. F., Dufton, M. J. and Hider, R. C., 1980. Eur. J. Biochem. 105: 623–630.
Lauterwein, J., Wutrich, K., Schweitz, H., Vincent, J. P. and Lazdunski, M., 1977. Biochem. Biophys. Res. Commun. 76: 1071–1078.
Lauterwein, J., Lazdunski, M. and Wutrich, K., 1978. Eur. J. Biochem. 92: 361–371.
Pezolet, M., Duchesneau, L., Bougis, P., Faucon, J. F. and Dufourcq, J., 1982. Biochim. Biophys. Acta 704: 515–523.
Wang, A. H. J. and Yang, C. C., 1981. J. Biol. Chem. 256: 9279–9282.
Fischer, J., Moras, D., Gilibert, M., Weiss, R. and Thierry, J. C., 1978. Acta Crystallogr. A34: 560.
Low, B. W., Preston, H. S., Sato, A., Rosen, L. S., Searl, J. E., Rudko, A. D. and Richardson, J. S., 1976. Proc. Natl. Acad. Sci. U.S.A. 73: 2991–2994.
Tsernoglou, D. and Petsko, G. A., 1976. FEBS Lett. 68: 1–4.
Conti-Tronconi, B. M. and Raftery, M. A., 1982. Ann. Rev. Biochem. (Snell, Boyer, Meiter, Richardson, eds.) Vol. 51, pp. 491–530, Annual Reviews Inc., Palo Alto, Cal. U.S.A.
Giraudat, J. and Changeux, J. P., 1980. TIPS 8: 198–202.
Lee, C.-Y., 1972. Ann. Rev. Pharmacol. (George, R. and Okun, R., eds.) Vol. 12, 265–286, Annual Reviews Inc. Palo Alto, Cal. U.S.A.
Sarkar, N. K., 1947. J. Ind. Chem. Soc. 24: 227–232.
Condrea, E., 1974. Experientia 30: 121–129.
Brisbois, L., Rabinovitch-Mahler, N., Delori, P. and Gillo, L., 1968. J. Chromatogr. 37: 463–475.
Fajnholc, N., Condrea, E. and De Vries, A., 1972. Biochim. Biophys. Acta 255: 850–857.
Lankish, P. G., Schoner, K., Schoner, W., Kunze, H., Bohn, E. and Vogt, W., 1972. Biochim. Biophys. Acta 266: 133–134.
Zaheer, A., Noronha, S. H., Hospattankar, A. V. and Braganca, B. M., 1975. Biochim. Biophys. Acta 394: 293–303.
Lin Shiau, S. Y., Liao, C. and Lee, C.-Y., 1977. Biochem. J. 161: 229–232.
Zaheer, A., Iyer, S. S. and Braganca, B. M., 1979. Cancer Biochem. Biophys. 3: 123–127.
Condrea, E., De Vries, A. and Mager, J., 1964. Biochim. Biophys. Acta 84: 60–73.
Braganca, B. M., Patel, N. J. and Bardinath, P. G., 1967. Biochim. Biophys. Acta 136: 508–520.
Lee, C.-Y. and Lee, S.-Y., 1979. Handbook of Experimental Pharmacology (Lee, C.-Y., ed.), Vol. 52, pp. 547–583, Springer-Verlag, Berlin, Heidelberg, New York.
Gulik-Krzywicki, T., Balerna, M., Vincent, J. P. and Lazdunski, M., 1981. Biochim. Biophys. Acta 643: 101–114.
Vogt, W., Patzer, P., Lege, L., Oldings, H. D. and Wille, G., 1970. Arch. Pharmacol. 265: 442–454.
Schroeter, R., Lankisch, P. G., Lege, L. and Vogt, W., 1972. Naunyn Schmiedebergs Arch. Pharmacol. 275: 203–211.
Patel, T. N., Braganca, B. M. and Bellare, R. A., 1969. Exp. Cell. Res. 57: 289–297.
Vincent, J. P., Schweitz, H., Chicheportiche, R., Fosset, M., Balerna, M., Lenoir, M. C. and Lazdunski, M., 1976. Biochemistry 15: 3171–3175.
Dufourcq, J. and Faucon, J. P., 1978. Biochemistry 17: 1170–1176.
Vincent, J. P., Balerna, M. and Lazdunski, M., 1978. FEBS Lett. 85: 103–108.
Faucon, J. F., Dufourcq, J., Couraud, F. and Rochat, H., 1979. Biochim. Biophys. Acta 554: 332–339.
Verger, R. and Pattus, F., 1982. Chem. Phys. Lipids 30: 189–227.
Bougis, P., Rochat, H., Pieroni, G. and Verger, R., 1981. Biochemistry 20: 4915–4920.
Rochat, H., Gregoire, J., Martin-Moutot, N., Menashe, M., Kopeyan, C. and Miranda, F., 1974. FEBS Lett. 42: 335–339.
Delori, P. and Tessier, M., 1980. Biochimie 62: 287–288.
Behrens, B. and Karber, C., 1935. Arch. Exp. Pathol. Pharmakol. 177: 379–384.
Liu, T. Y. and Chang, Y. H., 1971. J. Biol. Chem. 246: 2842–2848.
Crestfield, A. M., Moore, S. and Stein, W. H., 1963. J. Biol. Chem. 238: 622–627.
Edman, P. and Begg, G., 1977. Eur. J. Biochem. 1: 80–91.
Rochat, H., Bechis, G., Kopeyan, C., Gregoire, J. and Van Rietschoten, J., 1976. FEBS Lett. 64: 404–408.
Bosc-Bierne, I., Rathelot, J., Canioni, P., Julien, R., Bechis, G., Gregoire, J., Rochat, H. and Sarda, L., 1981. Biochim. Biophys. Acta 667: 225–232.
Hayashi, R., Moore, S. and Stein, W. H., 1973. J. Biol. Chem. 248: 2296–2302.
Drapeau, G. R., Boily, Y. and Houmard, J., 1972. J. Biol. Chem. 247: 6720–6726.
Thorell, J. I. and Johansson, B. G., 1971. Biochim. Biophys. Acta 251: 363–369.
Singleton, W. S., Gray, M. S., Brown, M. L. and White, J. L., 1965. J. Am. Oil Chem. Sec. 42: 53–56.
Rouser, G., Kritchevsky, G., Heller, D. and Lieber, E., 1963. J. Am.. Oil Chem. Soc. 40: 425–454.
Faucon, J. F., Bernard, E., Dufourcq, J., Pezolet, M. and Bougis, P., 1981. Biochimie 63: 857–861.
Shinitzky, M. and Barenholz, Y., 1974. J. Biol. Chem. 249: 2652–2657.
Felix, A. M. and Jimenez, M. H., 1973. Anal. Biochem. 52: 377–381.
Yamashiro, D. and Li, C. H., 1973. J. Org. Chem. 38: 2594–2597.
Rolland, M., Aquaron, R. and Lissitzky, S., 1970. Anal. Biochem. 33: 307–317.
Miranda, F., Kopeyan, C., Rochat, H., Rochat, C. and Lissitzky, S., 1970. Eur. J. Biochem. 16: 514–523.
Louw, A. I., 1974. Biochim. Biophys. Acta 336: 470–480.
Louw, A. I., 1974. Biochim. Biophys. Acta 336: 481–495.
Louw, A. I., 1974. Biochem. Biophys. Res. Commun. 58: 1022–1029.
Rochat, H., Tessier, M., Miranda, F. and Lissitzky, S., 1977. Anal. Biochem. 82: 532–548.
Huang, J. S., Liu, S. S., Ling, K. H., Chang, C. C. and Yang, C. C., 1973. Toxicon 11: 39–45.
Dufourcq, J., Faucon, J. F., Bernard, E., Pezolet, M., Tessier, M., Bougis, P., Van Rietschoten, J., Delori, P. and Rochat, H., 1982. Toxicon 20: 165–174.
Condrea, E., Kendjersky, I. and De Vries, A., 1965. Experientia 21: 461–464.
Verkleij, A. J., Zwaal, R. F. A., Roelofsen, B., Comfurius, P., Kastelijnn, D. and Van Deenen, L. L. M., 1973. Biochim. Biophys. Acta 323: 178–193.
Demel, R. A., Geurts Van Kessel, W. S. M., Zwaal, R. F. A., Roelofsen, B. and Van Deenen, L. L. M., 1975. Biochim. Biophys. Acta 406: 97–107.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bougis, P., Tessier, M., Van Rietschoten, J. et al. Are interactions with phospholipids responsible for pharmacological activities of cardiotoxins?. Mol Cell Biochem 55, 49–64 (1983). https://doi.org/10.1007/BF00229242
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00229242